<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01368588</url>
  </required_header>
  <id_info>
    <org_study_id>RTOG-0924</org_study_id>
    <secondary_id>CDR0000701128</secondary_id>
    <secondary_id>NCI-2011-02674</secondary_id>
    <nct_id>NCT01368588</nct_id>
    <nct_alias>NCT02673190</nct_alias>
  </id_info>
  <brief_title>Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer</brief_title>
  <official_title>Androgen Deprivation Therapy and High Dose Radiotherapy With or Without Whole-Pelvic Radiotherapy in Unfavorable Intermediate or Favorable High Risk Prostate Cancer: A Phase III Randomized Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Radiation Therapy Oncology Group</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Cancer Institute (NCI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>NRG Oncology</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Radiation Therapy Oncology Group</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      RATIONALE: Androgens can cause the growth of prostate cancer cells. Androgen deprivation
      therapy may stop the adrenal glands from making androgens. Radiation therapy uses high-energy
      x-rays to kill tumor cells.

      PURPOSE: This randomized phase III trial studies androgen-deprivation therapy and radiation
      therapy in treating patients with prostate cancer.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      OBJECTIVES:

      Primary

        -  Demonstrate that prophylactic, neoadjuvant, androgen-deprivation therapy (NADT) and
           whole-pelvic radiation therapy (WPRT) will result in improvement in overall survival
           (OS) of patients with &quot;unfavorable&quot; intermediate-risk or &quot;favorable&quot; high-risk prostate
           cancer compared to NADT and high-dose prostate (P) and seminal vesicle (SV) radiation
           therapy (RT) using intensity-modulated RT (IMRT) or external-beam RT (EBRT) with a
           high-dose rate (HDR) or a permanent prostate (radioactive seed) implant (PPI) boost.

      Secondary

        -  Demonstrate that prophylactic WPRT improves biochemical control.

        -  Determine the distant metastasis (DM)-free survival.

        -  Determine the cause-specific survival (CSS).

        -  Compare acute and late treatment-adverse events between patients receiving NADT and WPRT
           versus NADT, P, and SV RT.

        -  Determine whether health-related quality of life (HRQOL), as measured by the Expanded
           Prostate Cancer Index Composite (EPIC), significantly worsens with increasing
           aggressiveness of treatment (i.e., Arm 2, NADT + WPRT).

        -  Determine whether more aggressive treatment (Arm 2, NADT + WPRT) is associated with a
           greater increase in fatigue (PROMIS Fatigue Short Form) from baseline to last week of
           treatment, and a greater increase in circulating inflammatory markers (IL-1, IL-1ra,
           IL-6, tumor necrosis factor (TNF)-alpha, and C-reactive protein).

        -  Demonstrate an incremental gain in OS and CSS with more aggressive therapy that
           outweighs any detriments in the primary generic domains of HRQOL (i.e., mobility,
           self-care, usual activities, pain/discomfort, and anxiety/depression).

        -  Determine whether changes in fatigue from baseline to the next three time points (week
           prior to RT, last week of treatment, and 3 months after treatment) are associated with
           changes in circulating cytokines, mood, sleep, and daily activities across the same time
           points.

        -  Collect paraffin-embedded tissue blocks, plasma, whole blood, and urine for planned and
           future translational research analyses.

      OUTLINE: This is a multicenter study. Patients are stratified according to moderate- to
      high-risk groups as listed in the Disease Characteristics of this abstract, type of
      radiotherapy boost (IMRT vs brachytherapy [Low-dose rate (LDR) using PPI or HDR]), and
      duration of androgen-deprivation therapy (short-term [6 months] vs long-term [32 months]).
      Patients are randomized to 1 of 2 treatment arms.

      All patients receive neoadjuvant androgen-deprivation therapy comprising bicalutamide orally
      (PO) once daily or flutamide PO thrice daily for 6 months, and luteinizing hormone-releasing
      hormone (LHRH) agonist/antagonist therapy comprising leuprolide acetate, goserelin acetate,
      buserelin, triptorelin, or degarelix subcutaneously (SC) or intramuscularly (IM) every 1 to 3
      months beginning 2 months prior to radiotherapy and continuing for 6 or 32 months.

      Radiotherapy begins within 8 weeks after beginning LHRH agonist/antagonist injection.

        -  Arm I: Patients undergo high-dose radiotherapy of the prostate and seminal vesicles
           using intensity-modulated radiotherapy (IMRT)* or 3D-conformal radiation therapy
           (3D-CRT)* once daily, 5 days a week, for approximately 9 weeks. Patients may also
           undergo permanent prostate implant (PPI) brachytherapy or high-dose rate brachytherapy
           (iodine I 125 or palladium Pd 103 may be used as the radioisotope).

        -  Arm II: Patients undergo whole-pelvic radiotherapy (WPRT)* (3D-CRT or IMRT) once daily,
           5 days a week, for approximately 9 weeks. Patients may also undergo brachytherapy as in
           arm I.

      NOTE: * Patients undergoing brachytherapy implant receive 5 weeks of IMRT, 3D-CRT, or WPRT.

      Patients may undergo blood and urine sample collection for correlative studies. Primary tumor
      tissue samples may also be collected.

      Patients may complete the Expanded Prostate Cancer Index Composite (EPIC), the PROMIS-Fatigue
      Short Form, and the EuroQol (EQ-5D) quality-of-life (QOL) questionnaires at baseline and
      periodically during treatment. Patients who participate in the QOL portion of the study must
      also agree to periodic blood collection.

      After completion of study therapy, patients are followed up every 3 months for 1 year, every
      6 months for 3 years, and then yearly thereafter.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 2011</start_date>
  <primary_completion_date type="Anticipated">July 2027</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Overall Survival</measure>
    <time_frame>From date of randomization to the date of death.</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Cause-specific survival</measure>
    <time_frame>From date of randomization to the date of death due to prostate cancer.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Distant metastasis-free survival</measure>
    <time_frame>From date of randomization to the date of first documented distant metastasis or date of first clinical and/or radiographic appearance of disseminated disease.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Biochemical failure by the Phoenix definition (PSA â‰¥ 2 ng/mL over the nadir PSA)</measure>
    <time_frame>From date of randomization to the date of first biochemical failure by phoenix definition within 5 years of randomization.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of &quot;acute&quot; adverse events as assessed by the Common Toxicity Criteria for Adverse Effects (CTCAE) current version</measure>
    <time_frame>From protocol treatment start date to the date of first occurrence of worst severity of the adverse event &lt;/= 30 days from completion of radiation therapy.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to &quot;late&quot; grade 3+ adverse events as assessed by CTCAE current version</measure>
    <time_frame>From protocol treatment start date to the date of the first late grade 3+ adverse event occurring more than 30 days after the completion of radiation therapy.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Prostate cancer-specific HRQOL change as measured by the EPIC-26 (bowel or urinary domain)</measure>
    <time_frame>Date when baseline EPIC-26 completed to 6 months post radiation therapy, 1 year post radiation therapy and 5 years post radiation therapy.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fatigue status as measured by the Patient-Reported Outcome Measurement Information System (PROMIS) fatigue-domain change score</measure>
    <time_frame>From the date when the baseline PROMIS is completed to the last week of treatment.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Assessment and comparison of Quality Adjusted Life Years (QALYs)</measure>
    <time_frame>From the baseline QALYs assessment to the last week of radiation therapy (RT), 3 months post RT, 6 months post RT, 1 year post RT and 5 years post RT.</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">2580</enrollment>
  <condition>Prostate Cancer</condition>
  <arm_group>
    <arm_group_label>Arm I</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients undergo high-dose radiotherapy of the prostate and seminal vesicles using intensity-modulated radiotherapy (IMRT)* or 3D-conformal radiation therapy (3D-CRT)* once daily, 5 days a week, for approximately 9 weeks. Patients may also undergo permanent prostate implant (PPI) brachytherapy or high-dose rate brachytherapy (I 125 or Pd 103 may be used as the radioisotope).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm II</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients undergo whole-pelvic radiotherapy (WPRT)* (3D-CRT or IMRT) once daily, 5 days a week, for approximately 9 weeks. Patients may also undergo brachytherapy as in arm I.</description>
  </arm_group>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>radiation therapy</intervention_name>
    <description>Undergo RT using IMRT or 3D-CRT</description>
    <arm_group_label>Arm I</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>Whole-pelvic radiotherapy (WPRT)</intervention_name>
    <description>Undergo whole-pelvic radiotherapy (WPRT)</description>
    <arm_group_label>Arm II</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        DISEASE CHARACTERISTICS:

          -  Pathologically (histologically or cytologically) proven diagnosis of prostatic
             adenocarcinoma within 180 days of registration at moderate- to high-risk for
             recurrence as determined by one of the following combinations:

               -  Gleason score 7-10 + T1c-T2b (palpation) + prostate-specific antigen (PSA) &lt; 50
                  ng/mL (includes intermediate- and high-risk patients)

               -  Gleason score 6 + T2c-T4 (palpation) + PSA &lt; 50 ng/mL OR

               -  Gleason score 6 + &gt;= 50% (positive) biopsies + PSA &lt; 50 ng/ml

               -  Gleason score 6 + T1c-T2b (palpation) + PSA &gt; 20 ng/mL Patients previously
                  diagnosed with low risk prostate cancer undergoing active surveillance who are
                  re-biopsied and found to have unfavorable intermediate risk disease or favorable
                  high risk disease according to the protocol criteria are eligible for enrollment
                  within 180 days of the repeat biopsy procedure.

          -  History and/or physical examination (to include at a minimum digital rectal
             examination of the prostate and examination of the skeletal system and abdomen) within
             90 days prior to registration

          -  Clinically negative lymph nodes as established by imaging (pelvic and/or abdominal CT
             or MR), (but not by nodal sampling, or dissection) within 90 days prior to
             registration

               -  Patients with lymph nodes equivocal or questionable by imaging are eligible if
                  the nodes are â‰¤ 1.5 cm

               -  Patients status post a negative lymph node dissection are not eligible

          -  No evidence of bone metastases (M0) on bone scan within 120 days prior to registration
             (Na F PET/CT is an acceptable substitute)

               -  Equivocal bone scan findings are allowed if plain films (or CT or MRI) are
                  negative for metastasis

          -  Baseline serum PSA value performed with an FDA-approved assay (e.g., Abbott,
             Hybritech) within 120 days prior to registration

          -  Study entry PSA should not be obtained during the following time frames:

               -  Ten-day period following prostate biopsy

               -  Following initiation of hormonal therapy

               -  Within 30 days after discontinuation of finasteride

               -  Within 90 days after discontinuation of dutasteride

        PATIENT CHARACTERISTICS:

          -  Zubrod performance status 0-1

          -  Absolute neutrophil count (ANC) â‰¥ 1,500/mmÂ³

          -  Platelet count â‰¥ 100,000/mmÂ³

          -  Hemoglobin (Hgb) â‰¥ 8.0 g/dL (transfusion or other intervention to achieve Hgb â‰¥ 8.0
             g/dL is acceptable)

          -  No prior invasive (except non-melanoma skin cancer) malignancy unless disease-free for
             a minimum of 3 years (1,095 days) and not in the pelvis

               -  E.g., carcinoma in situ of the oral cavity is permissible; however, patients with
                  prior history of bladder cancer are not allowed

               -  No prior hematological (e.g., leukemia, lymphoma, or myeloma) malignancy

               -  No previous radical surgery (prostatectomy) or cryosurgery for prostate cancer

               -  No previous pelvic irradiation, prostate brachytherapy or bilateral orchiectomy

               -  No previous hormonal therapy, such as LHRH agonists (e.g., leuprolide, goserelin,
                  buserelin, triptorelin) or LHRH antagonist (e.g. degarelix), anti-androgens
                  (e.g., flutamide, bicalutamide, cyproterone acetate), estrogens (e.g., DES), or
                  surgical castration (orchiectomy)

          -  Prior pharmacologic androgen ablation for prostate cancer is allowed only if the onset
             of androgen ablation (both LHRH agonist and oral anti-androgen) is â‰¤ 45 days prior to
             the date of registration.

          -  No severe, active co-morbidity, defined as any of the following:

               -  Unstable angina and/or congestive heart failure requiring hospitalization within
                  the last 6 months

               -  Transmural myocardial infarction within the last 6 months

               -  Acute bacterial or fungal infection requiring intravenous antibiotics at the time
                  of registration

               -  Chronic obstructive pulmonary disease exacerbation or other respiratory illness
                  requiring hospitalization or precluding study therapy at the time of registration

               -  Hepatic insufficiency resulting in clinical jaundice and/or coagulation defects
                  or severe liver dysfunction

               -  Acquired immune deficiency syndrome (AIDS) based upon current Centers for Disease
                  Control (CDC) definition

                    -  Protocol-specific requirements may also exclude immuno-compromised patients

                    -  HIV testing is not required for entry into this protocol

          -  No patients who are sexually active and not willing/able to use medically acceptable
             forms of contraception

          -  No prior allergic reaction to the hormones involved in this protocol

        PRIOR CONCURRENT THERAPY:

          -  See Disease Characteristics

          -  No prior radical surgery (prostatectomy) or cryosurgery for prostate cancer

          -  No prior pelvic irradiation, prostate brachytherapy, or bilateral orchiectomy

          -  No prior hormonal therapy, such as luteinizing hormone-releasing hormone (LHRH)
             agonists (e.g., leuprolide, goserelin, buserelin, triptorelin) or LHRH antagonist
             (e.g., degarelix), anti-androgens (e.g., flutamide, bicalutamide, cyproterone
             acetate), estrogens (e.g., diethylstilbestrol (DES) ), or surgical castration
             (orchiectomy)

          -  No prior pharmacologic androgen ablation for prostate cancer unless the onset of
             androgen ablation is â‰¤ 45 days prior to the date of registration

          -  No finasteride within 30 days prior to registration

          -  No dutasteride or dutasteride/tamsulosin (Jalyn) within 90 days prior to registration

          -  No prior or concurrent cytotoxic chemotherapy for prostate cancer

               -  Prior chemotherapy for a different cancer is allowable

          -  No prior radiotherapy, including brachytherapy, to the region of the study cancer that
             would result in overlap of radiation therapy fields
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mack Roach, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of California, San Francisco</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Providence Cancer Center</name>
      <address>
        <city>Anchorage</city>
        <state>Alaska</state>
        <zip>99508</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clinical Trials Office - Providence Cancer Center</last_name>
      <phone>907-261-3109</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Arizona Center for Cancer Care - Peoria</name>
      <address>
        <city>Peoria</city>
        <state>Arizona</state>
        <zip>85381</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Terry T. Lee</last_name>
      <phone>623-773-2873</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Saint Agnes Cancer Center at Saint Agnes Medical Center</name>
      <address>
        <city>Fresno</city>
        <state>California</state>
        <zip>93720</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clinical Trials Office - Saint Agnes Cancer Center</last_name>
      <phone>559-450-7790</phone>
      <email>medresearch@samc.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Veterans Affairs Medical Center - Long Beach</name>
      <address>
        <city>Long Beach</city>
        <state>California</state>
        <zip>90822</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Samar H. Azawi, MD</last_name>
      <phone>562-826-5606</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai Medical Center</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90048</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Howard M. Sandler, MD</last_name>
      <phone>734-936-9338</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Memorial Medical Center</name>
      <address>
        <city>Modesto</city>
        <state>California</state>
        <zip>95355</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clinical Trials Office - Memorial Medical Center</last_name>
      <phone>209-572-7116</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Kaiser Permanente - Division of Research - Oakland</name>
      <address>
        <city>Oakland</city>
        <state>California</state>
        <zip>94611</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Louis Fehrenbacher, MD</last_name>
      <phone>707-651-2577</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Kaiser Permanente Medical Center - Rancho Cordova</name>
      <address>
        <city>Rancho Cordova</city>
        <state>California</state>
        <zip>95670</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Louis Fehrenbacher, MD</last_name>
      <phone>707-651-2577</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Rohnert Park Cancer Center</name>
      <address>
        <city>Rohnert Park</city>
        <state>California</state>
        <zip>94928</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Louis Fehrenbacher, MD</last_name>
      <phone>707-651-2577</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Kaiser Permanente Medical Center - Roseville</name>
      <address>
        <city>Roseville</city>
        <state>California</state>
        <zip>95678</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Louis Fehrenbacher, MD</last_name>
      <phone>707-651-2577</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of California Davis Cancer Center</name>
      <address>
        <city>Sacramento</city>
        <state>California</state>
        <zip>95817</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clinical Trials Office - University of California Davis Cancer</last_name>
      <phone>916-734-3089</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>South Sacramento Cancer Center</name>
      <address>
        <city>Sacramento</city>
        <state>California</state>
        <zip>95823</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Louis Fehrenbacher, MD</last_name>
      <phone>707-651-2577</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>UCSF Helen Diller Family Comprehensive Cancer Center</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94115</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clinical Trials Office - UCSF Helen Diller Family Comprehensi</last_name>
      <phone>877-827-3222</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Santa Clara Valley Medical Center</name>
      <address>
        <city>San Jose</city>
        <state>California</state>
        <zip>95128</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tri M. Do</last_name>
      <phone>408-885-5000</phone>
    </contact>
  </location>
  <location>
    <facility>
      <address>
        <city>Santa Clara</city>
        <state>California</state>
        <zip>95051</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Louis Fehrenbacher, MD</last_name>
      <phone>707-651-2577</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Kaiser Permanente Medical Center - South San Francisco</name>
      <address>
        <city>South San Francisco</city>
        <state>California</state>
        <zip>94080</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Louis Fehrenbacher, MD</last_name>
      <phone>707-651-2577</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Rocky Mountain Cancer Centers - Aurora</name>
      <address>
        <city>Aurora</city>
        <state>Colorado</state>
        <zip>80012</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eduardo R. Pajon, MD</last_name>
      <phone>303-399-8020</phone>
      <phone_ext>2261</phone_ext>
    </contact>
  </location>
  <location>
    <facility>
      <name>McKee Medical Center</name>
      <address>
        <city>Loveland</city>
        <state>Colorado</state>
        <zip>80539</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eduardo R. Pajon, MD</last_name>
      <phone>303-399-8020</phone>
      <phone_ext>2261</phone_ext>
    </contact>
  </location>
  <location>
    <facility>
      <name>St. Vincent's Medical Center</name>
      <address>
        <city>Bridgeport</city>
        <state>Connecticut</state>
        <zip>06606</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christopher M. Iannuzzi</last_name>
      <phone>203-576-6000</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>CCOP - Christiana Care Health Services</name>
      <address>
        <city>Newark</city>
        <state>Delaware</state>
        <zip>19713</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clinical Trial Office - CCOP - Christiana Care Health Services</last_name>
      <phone>302-623-4450</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>North Broward Medical Center</name>
      <address>
        <city>Deerfield Beach</city>
        <state>Florida</state>
        <zip>33064-3596</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clinical Trials Office - North Broward Medical Center</last_name>
      <phone>954-941-8300</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Baptist Cancer Institute - Jacksonville</name>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <zip>32207</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clinical Trials Office - Baptist Cancer Institute - Jacksonvil</last_name>
      <phone>904-202-7051</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Baptist Medical Center South</name>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <zip>32258</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael R. Olson</last_name>
      <phone>904-821-6000</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ella Milbank Foshay Cancer Center at Jupiter Medical Center</name>
      <address>
        <city>Jupiter</city>
        <state>Florida</state>
        <zip>33458</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clinical Trials Office - Ella Milbank Foshay Cancer Center</last_name>
      <phone>561-745-5768</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Florida Cancer Center - Palatka</name>
      <address>
        <city>Palatka</city>
        <state>Florida</state>
        <zip>32177</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael R. Olson</last_name>
      <phone>386-325-8140</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>21st Century Oncology - Plantation</name>
      <address>
        <city>Plantation</city>
        <state>Florida</state>
        <zip>33324</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christopher T. Chen</last_name>
      <phone>954-370-7555</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Emory Crawford Long Hospital</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30308</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ashesh B. Jani</last_name>
      <phone>773-702-2526</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Piedmont Hospital</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30309</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Adam W. Nowlan</last_name>
      <phone>404-605-5000</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Winship Cancer Institute of Emory University</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30322</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clinical Trials Office - Winship Cancer Institute</last_name>
      <phone>404-778-1900</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>John B. Amos Cancer Center</name>
      <address>
        <city>Columbus</city>
        <state>Georgia</state>
        <zip>31904</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clinical Trials Office - John B. Amos Cancer Center</last_name>
      <phone>706-660-6404</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Queen's Cancer Institute at Queen's Medical Center</name>
      <address>
        <city>Honolulu</city>
        <state>Hawaii</state>
        <zip>96813</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Paul A. DeMare, MD, FACR</last_name>
      <phone>808-547-4771</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Saint Alphonsus Cancer Care Center at Saint Alphonsus Regional Medical Center</name>
      <address>
        <city>Boise</city>
        <state>Idaho</state>
        <zip>83706</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clinical Trials Office - Saint Alphonsus Cancer Care Center</last_name>
      <phone>208-367-7954</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Northwest Community Hospital</name>
      <address>
        <city>Arlington Heights</city>
        <state>Illinois</state>
        <zip>60005</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stephen S. Nigh, MD</last_name>
      <phone>847-618-6560</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Cancer Institute at St. John's Hospital</name>
      <address>
        <city>Springfield</city>
        <state>Illinois</state>
        <zip>62702</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cathy L. Clausen, MD</last_name>
      <phone>765-646-8358</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Radiation Oncology Associates Southwest</name>
      <address>
        <city>Fort Wayne</city>
        <state>Indiana</state>
        <zip>46804</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Brian K. Chang</last_name>
      <phone>260-436-4116</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>McFarland Clinic, PC</name>
      <address>
        <city>Ames</city>
        <state>Iowa</state>
        <zip>50010</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clinical Trials Office - McFarland Clinic, PC</last_name>
      <phone>515-239-2621</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Kansas Masonic Cancer Research Institute at the University of Kansas Medical Center</name>
      <address>
        <city>Kansas City</city>
        <state>Kansas</state>
        <zip>66160-7357</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clinical Trials Office - Kansas Masonic Cancer Research Instit</last_name>
      <phone>913-588-4709</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Kansas City Cancer Centers - Southwest</name>
      <address>
        <city>Overland Park</city>
        <state>Kansas</state>
        <zip>66210</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fen Wang</last_name>
      <phone>913-234-0400</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Cotton-O'Neil Cancer Center</name>
      <address>
        <city>Topeka</city>
        <state>Kansas</state>
        <zip>66606</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clinical Trials Office - Cotton-O'Neil Cancer Center</last_name>
      <phone>785-270-4963</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Lucille P. Markey Cancer Center at University of Kentucky</name>
      <address>
        <city>Lexington</city>
        <state>Kentucky</state>
        <zip>40536-0093</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clinical Trials Office - Markey Cancer Center at University of</last_name>
      <phone>859-257-3379</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Tulane Cancer Center Office of Clinical Research</name>
      <address>
        <city>Alexandria</city>
        <state>Louisiana</state>
        <zip>71315-3198</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clinical Trials Office - Tulane Cancer Center</last_name>
      <phone>504-988-6121</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Mary Bird Perkins Cancer Center - Baton Rouge</name>
      <address>
        <city>Baton Rouge</city>
        <state>Louisiana</state>
        <zip>70809</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Robert W. Veith</last_name>
      <phone>225-767-0847</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Greenebaum Cancer Center at University of Maryland Medical Center</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21201</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clinical Trials Office - Greenebaum Cancer Center at Universit</last_name>
      <phone>800-888-8823</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>St. Agnes Hospital Cancer Center</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21229</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Richard S. Hudes, MD</last_name>
      <phone>410-368-2965</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Central Maryland Oncology Center</name>
      <address>
        <city>Columbia</city>
        <state>Maryland</state>
        <zip>21044</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Young Kwok</last_name>
      <phone>410-964-2212</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Tate Cancer Center at Baltimore Washington Medical Center</name>
      <address>
        <city>Glen Burnie</city>
        <state>Maryland</state>
        <zip>21061</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Young Kwok</last_name>
      <phone>410-553-8100</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hudner Oncology Center at Saint Anne's Hospital - Fall River</name>
      <address>
        <city>Fall River</city>
        <state>Massachusetts</state>
        <zip>02721</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clinical Trials Office - Hudner Oncology Center at Saint Anne'</last_name>
      <phone>508-674-5600</phone>
      <phone_ext>2019</phone_ext>
    </contact>
  </location>
  <location>
    <facility>
      <name>Cape Cod Hospital</name>
      <address>
        <city>Hyannis</city>
        <state>Massachusetts</state>
        <zip>02601</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Daniel J. Canaday</last_name>
      <phone>508-771-1800</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Lowell General Hospital</name>
      <address>
        <city>Lowell</city>
        <state>Massachusetts</state>
        <zip>01854</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jeffrey D. Goldstein</last_name>
      <phone>978-937-6000</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hickman Cancer Center at Bixby Medical Center</name>
      <address>
        <city>Adrian</city>
        <state>Michigan</state>
        <zip>49221</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clinical Trials Office - Hickman Cancer Center at Bixby Medica</last_name>
      <phone>517-265-0116</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Josephine Ford Cancer Center at Henry Ford Hospital</name>
      <address>
        <city>Detroit</city>
        <state>Michigan</state>
        <zip>48202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eleanor M. Walker, MD</last_name>
      <phone>313-916-1021</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Butterworth Hospital at Spectrum Health</name>
      <address>
        <city>Grand Rapids</city>
        <state>Michigan</state>
        <zip>49503</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gilbert D.A. Padula</last_name>
      <phone>616-391-2799</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Lacks Cancer Center at Saint Mary's Health Care</name>
      <address>
        <city>Grand Rapids</city>
        <state>Michigan</state>
        <zip>49503</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gilbert D.A. Padula</last_name>
      <phone>616-752-5222</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>St. Mary Mercy Hospital</name>
      <address>
        <city>Livonia</city>
        <state>Michigan</state>
        <zip>48154</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Samir Narayan</last_name>
      <phone>734-464-4800</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Seton Cancer Institute at Saint Mary's - Saginaw</name>
      <address>
        <city>Saginaw</city>
        <state>Michigan</state>
        <zip>48601</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clinical Trials Office - Seton Cancer Institute - Saginaw</last_name>
      <phone>989-776-8411</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Albert Lea Cancer Center at Albert Lea Medical Center</name>
      <address>
        <city>Albert Lea</city>
        <state>Minnesota</state>
        <zip>56007</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Timothy F. Kozelsky, MD</last_name>
      <phone>507-379-2050</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Immanuel St. Joseph's</name>
      <address>
        <city>Mankato</city>
        <state>Minnesota</state>
        <zip>56002</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ron S. Smith</last_name>
      <phone>507-345-2929</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Regional Cancer Center at Singing River Hospital</name>
      <address>
        <city>Pascagoula</city>
        <state>Mississippi</state>
        <zip>39581</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>James E. Clarkson, MD</last_name>
      <phone>228-374-6296</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Kansas City Cancer Centers - South</name>
      <address>
        <city>Kansas City</city>
        <state>Missouri</state>
        <zip>64131</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fen Wang</last_name>
      <phone>816-333-1326</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Kansas City Cancer Centers - North</name>
      <address>
        <city>Kansas City</city>
        <state>Missouri</state>
        <zip>64154</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fen Wang</last_name>
      <phone>816-746-4570</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Kansas City Cancer Centers - East</name>
      <address>
        <city>Lee's Summit</city>
        <state>Missouri</state>
        <zip>64064</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fen Wang</last_name>
      <phone>816-478-2050</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Siteman Cancer Center at Barnes-Jewish Hospital - Saint Louis</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63110</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jeff M. Michalski, MD</last_name>
      <phone>314-362-8566</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Siteman Cancer Center at Barnes-Jewish St. Peters Hospital - St. Peters</name>
      <address>
        <city>Saint Peters</city>
        <state>Missouri</state>
        <zip>63376</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jeff M. Michalski, MD</last_name>
      <phone>314-362-8566</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hulston Cancer Center at Cox Medical Center South</name>
      <address>
        <city>Springfield</city>
        <state>Missouri</state>
        <zip>65807</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Robert L. Carolla</last_name>
      <phone>417-269-5257</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Renown Institute for Cancer at Renown Regional Medical Center</name>
      <address>
        <city>Reno</city>
        <state>Nevada</state>
        <zip>89502</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Daniel W. Weed</last_name>
      <phone>775-982-5050</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Norris Cotton Cancer Center at Dartmouth-Hitchcock Medical Center</name>
      <address>
        <city>Lebanon</city>
        <state>New Hampshire</state>
        <zip>03756-0002</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clinical Trials Office - Norris Cotton Cancer Center</last_name>
      <phone>603-650-7609</phone>
      <email>cancerhelp@dartmouth.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Frederick R. and Betty M. Smith Cancer Treatment Center</name>
      <address>
        <city>Sparta</city>
        <state>New Jersey</state>
        <zip>07871</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maria Werner-Wasik, MD</last_name>
      <phone>215-955-7679</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>New York Methodist Hospital</name>
      <address>
        <city>Brooklyn</city>
        <state>New York</state>
        <zip>11215</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sameer Rafla-Demetrious, MD, PhD, FRCR, FACR, FRSM</last_name>
      <phone>718-780-3677</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Long Island Jewish Medical Center</name>
      <address>
        <city>New Hyde Park</city>
        <state>New York</state>
        <zip>11040</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Louis Potters, MD, FACR</last_name>
      <phone>516-632-3370</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill</name>
      <address>
        <city>Chapel Hill</city>
        <state>North Carolina</state>
        <zip>27599-7295</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clinical Trials Office - Lineberger Comprehensive Cancer Cente</last_name>
      <phone>877-668-0683</phone>
    </contact>
    <contact_backup>
      <last_name>Clinical Trials Office</last_name>
      <phone>919-966-4432</phone>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Duke Cancer Institute</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27710</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clinical Trials Office - Duke Cancer Institute</last_name>
      <phone>888-275-3853</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Coleman Radiation Oncology Center at Carter General Hospital</name>
      <address>
        <city>Morehead City</city>
        <state>North Carolina</state>
        <zip>28557</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael A. Papagikos</last_name>
      <phone>252-808-6191</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>FirstHealth Moore Regional Community Hospital Comprehensive Cancer Center</name>
      <address>
        <city>Pinehurst</city>
        <state>North Carolina</state>
        <zip>28374</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clinical Trials Office - FirstHealth Moore Regional Community</last_name>
      <phone>910-715-2200</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>South Atlantic Radiation Oncology, LLC</name>
      <address>
        <city>Supply</city>
        <state>North Carolina</state>
        <zip>28462</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael A. Papagikos</last_name>
      <phone>910-754-4716</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Coastal Carolina Radiation Oncology Center</name>
      <address>
        <city>Wilmington</city>
        <state>North Carolina</state>
        <zip>28401</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael A. Papagikos</last_name>
      <phone>910-251-1839</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Forsyth Regional Cancer Center at Forsyth Medical Center</name>
      <address>
        <city>Winston-Salem</city>
        <state>North Carolina</state>
        <zip>27103</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clinical Trials Office - Forsyth Regional Cancer Center at For</last_name>
      <phone>336-277-8887</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Wake Forest University Comprehensive Cancer Center</name>
      <address>
        <city>Winston-Salem</city>
        <state>North Carolina</state>
        <zip>27157-1096</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clinical Trials Office - Wake Forest University Comprehensive</last_name>
      <phone>336-713-6771</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>CCOP - MeritCare Hospital</name>
      <address>
        <city>Fargo</city>
        <state>North Dakota</state>
        <zip>58122</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Preston D. Steen, MD</last_name>
      <phone>701-234-2397</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>McDowell Cancer Center at Akron General Medical Center</name>
      <address>
        <city>Akron</city>
        <state>Ohio</state>
        <zip>44307</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mitchell L. Fromm, MD</last_name>
      <phone>330-344-6448</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Summa Center for Cancer Care at Akron City Hospital</name>
      <address>
        <city>Akron</city>
        <state>Ohio</state>
        <zip>44309-2090</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clinical Trials Office - Akron City Hospital</last_name>
      <phone>330-375-6101</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Barberton Citizens Hospital</name>
      <address>
        <city>Barberton</city>
        <state>Ohio</state>
        <zip>44203</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>William F. Demas, MD</last_name>
      <phone>330-375-3557</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Adena Regional Medical Center</name>
      <address>
        <city>Chillicothe</city>
        <state>Ohio</state>
        <zip>45601</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clinical Trials Office - Adena Regional Medical Center</last_name>
      <phone>877-779-7585</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Case Comprehensive Cancer Center</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44106-5065</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clinical Trials Office - Case Comprehensive Cancer Center</last_name>
      <phone>800-641-2422</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Zangmeister Center</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43219</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>J. Philip Kuebler, MD, PhD</last_name>
      <phone>614-442-3130</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Lake/University Ireland Cancer Center</name>
      <address>
        <city>Mentor</city>
        <state>Ohio</state>
        <zip>44060</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rodney J. Ellis</last_name>
      <phone>440-205-5755</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Southwest General Health Center</name>
      <address>
        <city>Middleburg Heights</city>
        <state>Ohio</state>
        <zip>44130</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rodney J. Ellis</last_name>
      <phone>440-816-8000</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>UHHS Chagrin Highlands Medical Center</name>
      <address>
        <city>Orange</city>
        <state>Ohio</state>
        <zip>44122</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rodney J. Ellis</last_name>
      <phone>216-292-1783</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Cancer Care Center, Incorporated</name>
      <address>
        <city>Salem</city>
        <state>Ohio</state>
        <zip>44460</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>William F. Demas, MD</last_name>
      <phone>330-375-3557</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Flower Hospital Cancer Center</name>
      <address>
        <city>Sylvania</city>
        <state>Ohio</state>
        <zip>43560</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clinical Trials Office - Flower Hospital Cancer Center</last_name>
      <phone>419-824-1842</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>St. Anne Mercy Hospital</name>
      <address>
        <city>Toledo</city>
        <state>Ohio</state>
        <zip>43623</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rex B. Mowat</last_name>
      <phone>419-407-2663</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>UHHS Westlake Medical Center</name>
      <address>
        <city>Westlake</city>
        <state>Ohio</state>
        <zip>44145</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rodney J. Ellis</last_name>
      <phone>440-250-2001</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Cancer Treatment Center</name>
      <address>
        <city>Wooster</city>
        <state>Ohio</state>
        <zip>44691</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clinical Trials Office - Cancer Treatment Center</last_name>
      <phone>330-375-4221</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>United States Air Force Medical Center - Wright-Patterson</name>
      <address>
        <city>Wright-Patterson Air Force Base</city>
        <state>Ohio</state>
        <zip>45433-5529</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>William K.J. Skinner</last_name>
      <phone>937-257-9133</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Oklahoma University Cancer Institute</name>
      <address>
        <city>Oklahoma City</city>
        <state>Oklahoma</state>
        <zip>73104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Terence S. Herman</last_name>
      <phone>405-271-6822</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Clackamas Radiation Oncology Center</name>
      <address>
        <city>Clackamas</city>
        <state>Oregon</state>
        <zip>97015</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Matthew C. Solhjem</last_name>
      <phone>503-513-3300</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Dubs Cancer Center at Rogue Valley Medical Center</name>
      <address>
        <city>Medford</city>
        <state>Oregon</state>
        <zip>97504</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gordon L. Metz, MD</last_name>
      <phone>541-608-4263</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Providence Cancer Center at PMCC</name>
      <address>
        <city>Medford</city>
        <state>Oregon</state>
        <zip>97504</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gordon L. Metz, MD</last_name>
      <phone>541-608-4263</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Providence Cancer Center at Providence Portland Medical Center</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97213-2967</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clinical Trials Office - Providence Cancer Center at Providenc</last_name>
      <phone>503-215-6412</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Providence St. Vincent Medical Center</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97225</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clinical Trials Office - Providence St. Vincent Medical Center</last_name>
      <phone>503-215-6412</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Rosenfeld Cancer Center at Abington Memorial Hospital</name>
      <address>
        <city>Abington</city>
        <state>Pennsylvania</state>
        <zip>19001</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clinical Trials Office - Rosenfeld Cancer Center at Abington M</last_name>
      <phone>215-481-2402</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Adams Cancer Center</name>
      <address>
        <city>Gettysburg</city>
        <state>Pennsylvania</state>
        <zip>17325</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amir Tabatabai, MD</last_name>
      <phone>717-741-9229</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Cherry Tree Cancer Center</name>
      <address>
        <city>Hanover</city>
        <state>Pennsylvania</state>
        <zip>17331</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amir Tabatabai, MD</last_name>
      <phone>717-741-9229</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Penn State Hershey Cancer Institute at Milton S. Hershey Medical Center</name>
      <address>
        <city>Hershey</city>
        <state>Pennsylvania</state>
        <zip>17033-0850</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clinical Trials Office - Penn State Hershey Cancer Institute a</last_name>
      <phone>717-531-3779</phone>
      <email>CTO@hmc.psu.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Upper Delaware Valley Cancer Center</name>
      <address>
        <city>Milford</city>
        <state>Pennsylvania</state>
        <zip>18337</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maria Werner-Wasik, MD</last_name>
      <phone>215-955-7679</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Fox Chase Cancer Center - Philadelphia</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19111-2497</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clinical Trials Office - Fox Chase Cancer Center - Philadelphi</last_name>
      <phone>215-728-4790</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>McGlinn Family Regional Cancer Center at Reading Hospital and Medical Center</name>
      <address>
        <city>Reading</city>
        <state>Pennsylvania</state>
        <zip>19612-6052</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clinical Trials Office - McGlinn Family Regional Cancer Center</last_name>
      <phone>610-988-9323</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>York Cancer Center at Apple Hill Medical Center</name>
      <address>
        <city>York</city>
        <state>Pennsylvania</state>
        <zip>17405</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amir Tabatabai, MD</last_name>
      <phone>717-741-9229</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>CCOP - Greenville</name>
      <address>
        <city>Greenville</city>
        <state>South Carolina</state>
        <zip>29615</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David L. Grisell</last_name>
      <phone>864-241-6251</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Gibbs Regional Cancer Center at Spartanburg Regional Medical Center</name>
      <address>
        <city>Spartanburg</city>
        <state>South Carolina</state>
        <zip>29303</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clinical Trials Office - Gibbs Regional Cancer Center</last_name>
      <phone>800-486-5941</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Texas Medical Branch</name>
      <address>
        <city>Galveston</city>
        <state>Texas</state>
        <zip>77555-0361</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clinical Trials Office - University of Texas Medical Branch</last_name>
      <phone>409-772-1950</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Texas Health Science Center</name>
      <address>
        <city>San Antonio</city>
        <state>Texas</state>
        <zip>78229</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Carol A. Jenkins</last_name>
      <phone>210-450-5924</phone>
      <email>jenkinsca@uthscsa.edu</email>
    </contact>
    <investigator>
      <last_name>Tony Y. Eng, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Jon and Karen Huntsman Cancer Center at Intermountain Medical Center</name>
      <address>
        <city>Murray</city>
        <state>Utah</state>
        <zip>84157</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>R. Jeffrey Lee, MD</last_name>
      <phone>801-408-1146</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Utah Valley Regional Medical Center - Provo</name>
      <address>
        <city>Provo</city>
        <state>Utah</state>
        <zip>84604</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clinical Trials Office - Utah Valley Regional Medical Center -</last_name>
      <phone>801-357-7965</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Dixie Regional Medical Center - East Campus</name>
      <address>
        <city>Saint George</city>
        <state>Utah</state>
        <zip>84770</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clinical Trials Office - Dixie Regional Medical Center - East</last_name>
      <phone>435-688-4167</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Utah Cancer Specialists at UCS Cancer Center</name>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <zip>84106</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>R. Jeffrey Lee, MD</last_name>
      <phone>801-408-1146</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Norris Cotton Cancer Center - North</name>
      <address>
        <city>Saint Johnsbury</city>
        <state>Vermont</state>
        <zip>05819</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alan C. Hartford, MD, PhD</last_name>
      <phone>603-650-6600</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>RMH Regional Cancer Center at Rockingham Memorial Hospital</name>
      <address>
        <city>Harrisonburg</city>
        <state>Virginia</state>
        <zip>22801</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Heather Anne W. Morgan</last_name>
      <phone>540-564-5570</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Sentara Cancer Institute at Sentara Norfolk General Hospital</name>
      <address>
        <city>Norfolk</city>
        <state>Virginia</state>
        <zip>23507</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clinical Trials Office - Sentara Cancer Institute at Sentara N</last_name>
      <phone>757-388-2406</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Coastal Cancer Center at Sentara Virginia Beach General Hospital</name>
      <address>
        <city>Virginia Beach</city>
        <state>Virginia</state>
        <zip>23454</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mark E. Shaves</last_name>
      <phone>757-395-8686</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>CCOP - Virginia Mason Research Center</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98101</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Huong T. Pham, MD</last_name>
      <phone>206-223-6801</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>North Star Lodge Cancer Center at Yakima Valley Memorial Hospital</name>
      <address>
        <city>Yakima</city>
        <state>Washington</state>
        <zip>98902</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clinical Trails Office - North Star Lodge Cancer Center</last_name>
      <phone>509-574-3422</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Theda Care Cancer Institute</name>
      <address>
        <city>Appleton</city>
        <state>Wisconsin</state>
        <zip>54911</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clinical Trials Office - Theda Care Cancer Institute</last_name>
      <phone>920-380-1500</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Luther Midlelfort Hospital</name>
      <address>
        <city>Eau Claire</city>
        <state>Wisconsin</state>
        <zip>54703</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gopakumar S. Nambudiri</last_name>
      <phone>715-838-3311</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>St. Mary's Hospital Medical Center - Green Bay</name>
      <address>
        <city>Green Bay</city>
        <state>Wisconsin</state>
        <zip>54303</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gregory M. Cooley, MD</last_name>
      <phone>414-433-8184</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>St. Vincent Hospital Regional Cancer Center</name>
      <address>
        <city>Green Bay</city>
        <state>Wisconsin</state>
        <zip>54307-3508</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clinical Trials Office - St. Vincent Hospital Regional Cancer</last_name>
      <phone>920-433-8889</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Vince Lombardi Cancer Clinic - Green Bay at Aurora BayCare Medical Center</name>
      <address>
        <city>Green Bay</city>
        <state>Wisconsin</state>
        <zip>54311</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clinical Trials Office - Vince Lombardi Cancer Clinic - Green</last_name>
      <phone>414-649-5717</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Franciscan Skemp Healthcare - La Crosse Campus</name>
      <address>
        <city>La Crosse</city>
        <state>Wisconsin</state>
        <zip>54601</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michelle A. Neben-Wittich</last_name>
      <phone>608-785-0940</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Gundersen Lutheran Center for Cancer and Blood</name>
      <address>
        <city>La Crosse</city>
        <state>Wisconsin</state>
        <zip>54601</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clinical Trials Office - Gundersen Lutheran Cancer Center</last_name>
      <phone>608-775-2385</phone>
      <email>cancerctr@gundluth.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Bay Area Cancer Care Center at Bay Area Medical Center</name>
      <address>
        <city>Marinette</city>
        <state>Wisconsin</state>
        <zip>54143</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gregory M. Cooley, MD</last_name>
      <phone>414-433-8184</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Columbia Saint Mary's Hospital - Ozaukee</name>
      <address>
        <city>Mequon</city>
        <state>Wisconsin</state>
        <zip>53097</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Carl E. Olson, MD</last_name>
      <phone>414-291-1556</phone>
      <email>clinicaltrials@columbia-stmarys.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Columbia-Saint Mary's Water Tower Medical Commons</name>
      <address>
        <city>Milwaukee</city>
        <state>Wisconsin</state>
        <zip>53211</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clinical Trials Office - Columbia-St. Mary's Cancer Care Cente</last_name>
      <phone>414-326-1739</phone>
      <email>clinicaltrials@columbia-stmarys.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Vince Lombardi Cancer Clinic at Aurora St. Luke's Medical Center</name>
      <address>
        <city>Milwaukee</city>
        <state>Wisconsin</state>
        <zip>53215</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clinical Trials Office - Vince Lombardi Cancer Clinic</last_name>
      <phone>414-649-5717</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Medical College of Wisconsin Cancer Center</name>
      <address>
        <city>Milwaukee</city>
        <state>Wisconsin</state>
        <zip>53226</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clinical Trials Office - Medical College of Wisconsin Cancer C</last_name>
      <phone>414-805-4380</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Veterans Affairs Medical Center - Milwaukee</name>
      <address>
        <city>Milwaukee</city>
        <state>Wisconsin</state>
        <zip>53295</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Elizabeth M. Gore, MD</last_name>
      <phone>414-805-4369</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Vince Lombardi Cancer Clinic - Sheboygan</name>
      <address>
        <city>Sheboygan</city>
        <state>Wisconsin</state>
        <zip>53081</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clinical Trials Office - Vince Lombardi Cancer Clinic - Sheboy</last_name>
      <phone>414-649-7200</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Door County Cancer Center at Door County Memorial Hospital</name>
      <address>
        <city>Sturgeon Bay</city>
        <state>Wisconsin</state>
        <zip>54235-1495</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gregory M. Cooley, MD</last_name>
      <phone>414-433-8184</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Aurora Medical Center</name>
      <address>
        <city>Summit</city>
        <state>Wisconsin</state>
        <zip>53066</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David C. Rohde, MD</last_name>
      <phone>920-288-4160</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>West Allis Memorial Hospital</name>
      <address>
        <city>West Allis</city>
        <state>Wisconsin</state>
        <zip>53227</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clinical Trials Office - West Allis Memorial Hospital</last_name>
      <phone>414-649-5717</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Tom Baker Cancer Centre - Calgary</name>
      <address>
        <city>Calgary</city>
        <state>Alberta</state>
        <zip>T2N 4N2</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael A. Sia</last_name>
      <phone>403-521-3723</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Cross Cancer Institute at University of Alberta</name>
      <address>
        <city>Edmonton</city>
        <state>Alberta</state>
        <zip>T6G 1Z2</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Brita L. Danielson</last_name>
      <phone>780-432-8771</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>British Columbia Cancer Agency - Centre for the Southern Interior</name>
      <address>
        <city>Kelowna</city>
        <state>British Columbia</state>
        <zip>V1Y 5L3</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Juanita M. Crook</last_name>
      <phone>250-712-3900</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Doctor H. Bliss Murphy Cancer Centre</name>
      <address>
        <city>Saint John's</city>
        <state>Newfoundland and Labrador</state>
        <zip>A1B 3V6</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>John W. Thoms</last_name>
      <phone>709-777-7589</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Nova Scotia Cancer Centre</name>
      <address>
        <city>Halifax</city>
        <state>Nova Scotia</state>
        <zip>B3H 1V8</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David M.C. Bowes</last_name>
      <phone>902-473-6000</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>London Regional Cancer Program at London Health Sciences Centre</name>
      <address>
        <city>London</city>
        <state>Ontario</state>
        <zip>N6A 4L6</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>George B. Rodrigues</last_name>
      <phone>519-685-8615</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Odette Cancer Centre at Sunnybrook</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M4N 3M5</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hans T. Chung</last_name>
      <phone>416-480-5000</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hopital Notre-Dame du CHUM</name>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <zip>H2L 4M1</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jean-Paul Bahary</last_name>
      <phone>514-281-6000</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>McGill Cancer Centre at McGill University</name>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <zip>H2W 1S6</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fabio L.B. Cury</last_name>
      <phone>514-398-1444</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire de Quebec</name>
      <address>
        <city>Quebec City</city>
        <state>Quebec</state>
        <zip>G1R 2J6</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eric Vigneault</last_name>
      <phone>418-525-4444</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Allan Blair Cancer Centre at Pasqua Hospital</name>
      <address>
        <city>Regina</city>
        <state>Saskatchewan</state>
        <zip>S4T 7T1</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Evgeny Sadikov</last_name>
      <phone>306-766-2203</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Saskatoon Cancer Centre at the University of Saskatchewan</name>
      <address>
        <city>Saskatoon</city>
        <state>Saskatchewan</state>
        <zip>S7N 4H4</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ali A. El-Gayed</last_name>
      <phone>306-655-2662</phone>
    </contact>
  </location>
  <location_countries>
    <country>Canada</country>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 7, 2011</study_first_submitted>
  <study_first_submitted_qc>June 7, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 8, 2011</study_first_posted>
  <last_update_submitted>May 18, 2017</last_update_submitted>
  <last_update_submitted_qc>May 18, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 19, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>adenocarcinoma of the prostate</keyword>
  <keyword>stage I prostate cancer</keyword>
  <keyword>stage IIA prostate cancer</keyword>
  <keyword>stage IIB prostate cancer</keyword>
  <keyword>stage III prostate cancer</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Prostatic Neoplasms</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Androgens</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

